Advances in the development of new biomarkers for Alzheimer's disease
TO Klyucherev, P Olszewski, AA Shalimova… - Translational …, 2022 - Springer
Alzheimer's disease (AD) is a complex, heterogeneous, progressive disease and is the most
common type of neurodegenerative dementia. The prevalence of AD is expected to increase …
common type of neurodegenerative dementia. The prevalence of AD is expected to increase …
Biomarker of neuroinflammation in Parkinson's disease
Parkinson's disease (PD) is caused by abnormal accumulation of α-synuclein in
dopaminergic neurons of the substantia nigra, which subsequently causes motor symptoms …
dopaminergic neurons of the substantia nigra, which subsequently causes motor symptoms …
[HTML][HTML] Inflammation as a central mechanism in Alzheimer's disease
JW Kinney, SM Bemiller, AS Murtishaw… - Alzheimer's & Dementia …, 2018 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized
by cognitive decline and the presence of two core pathologies, amyloid β plaques and …
by cognitive decline and the presence of two core pathologies, amyloid β plaques and …
The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer's disease
N Lonnemann, S Hosseini… - Proceedings of the …, 2020 - National Acad Sciences
Numerous studies demonstrate that neuroinflammation is a key player in the progression of
Alzheimer's disease (AD). Interleukin (IL)-1β is a main inducer of inflammation and therefore …
Alzheimer's disease (AD). Interleukin (IL)-1β is a main inducer of inflammation and therefore …
Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation
B Lima Giacobbo, J Doorduin, HC Klein… - Molecular …, 2019 - Springer
Brain-derived neurotrophic factor (BDNF) is one of the most studied neurotrophins in the
healthy and diseased brain. As a result, there is a large body of evidence that associates …
healthy and diseased brain. As a result, there is a large body of evidence that associates …
Ageing, cellular senescence and neurodegenerative disease
M Kritsilis, S V. Rizou, PN Koutsoudaki… - International journal of …, 2018 - mdpi.com
Ageing is a major risk factor for developing many neurodegenerative diseases. Cellular
senescence is a homeostatic biological process that has a key role in driving ageing. There …
senescence is a homeostatic biological process that has a key role in driving ageing. There …
Cellular senescence in neurodegenerative diseases
C Martínez-Cué, N Rueda - Frontiers in cellular neuroscience, 2020 - frontiersin.org
Cellular senescence is a homeostatic biological process characterized by a permanent state
of cell cycle arrest that can contribute to the decline of the regenerative potential and …
of cell cycle arrest that can contribute to the decline of the regenerative potential and …
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?
The state of the intestinal environment can have profound effects on the activity of the central
nervous system through the physiological contributions of the microbiota, regulation of …
nervous system through the physiological contributions of the microbiota, regulation of …
Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis
Importance The association of nonmotor features and Parkinson disease (PD) is
increasingly recognized. Evidence suggests that inflammation may play a role in PD …
increasingly recognized. Evidence suggests that inflammation may play a role in PD …
Rheumatoid arthritis: recent advances on its etiology, role of cytokines and pharmacotherapy
J Alam, I Jantan, SNA Bukhari - Biomedicine & pharmacotherapy, 2017 - Elsevier
An autoimmune disease is defined as a clinical syndrome resulted from an instigation of
both T cell and B cell or individually, in the absence of any present infection or any sort of …
both T cell and B cell or individually, in the absence of any present infection or any sort of …